Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

Patient Experience: Living with multiple rare diseases

February 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma, rare disease

Carole Scrafton discusses her experience living with Ehlers-Danlos syndrome alongside other rare conditions that have manifested throughout her life, and …

Feature
eisa0008_web

Eisai releases new Phase 2 data for levatinib+everolimus combo in advanced kidney cancer

February 17, 2020
Research and Development, Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, pharma, renal cell carcinoma

New Phase 2 data has been revealed for Eisai’s Lenvima (levatinib), delivered alongside Novartis’ everolimus, for the treatment of unresectable …

News
entrance_takeda_i020_v1

Strong Phase 3 data for Takeda’s subcutaneous Entyvio in moderate to severe Crohn’s disease

February 17, 2020
Research and Development, Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma

Takeda has shared positive new Phase 3 data on a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab) as a …

News
vaccination-1215279_960_720

Mumps cases in England rocket four-fold to highest point in a decade

February 14, 2020
Medical Communications, Research and Development MMR vaccine, Vaccine, anti-vaccine, pharma

The incidence of mumps in the England has reached its highest level in 10 years, prompting warnings from health officials …

News
6127243966_e9189f1099_b

Global drug market’s production line threatened by coronavirus

February 14, 2020
Medical Communications Chinese Coronavirus, Drug markets, Wuhan Coronavirus, china epidemic, coronavirus, drugs, epidemic, pharma

The global drug market is facing issues over production due to the coronavirus ravaging the supply line from China. In …

News
eisa0008_web

Eisai withdraws weight loss drug Belviq after FDA highlights cancer risk

February 14, 2020
Medical Communications, Research and Development, Sales and Marketing Belviq, Eisai, FDA, pharma

The FDA has requested that Eisai withdraw its weight loss drug Belviq (lorcaserin) and Belviq XR from the US market …

News

Sanofi axes four major players from its executive committee

February 13, 2020
Manufacturing and Production, Medical Communications Sanofi, appointments, pharma

Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief Executive Officer Paul Hudson, who …

News
shutterstock_159488225

Lilly and Incyte’s atopic dermatitis drug shows promise at Phase 3

February 13, 2020
Sales and Marketing Eli Lilly, Incyte, baricitinib, pharma

Eli Lilly and Incyte have pulled back the curtain on Phase 3 data on their oral selective JAK inhibitor baricitinib …

News
cancer-vs-alzheimer-1080x810

ICR identifies key “microRNA” gene driving chemotherapy resistance in cancer

February 12, 2020
Research and Development Cancer, ICR, pharma

Researchers at the Institute of Cancer Research have discovered that a small RNA molecule known as microRNA gene MIR1249 contributes …

News
andrea_pfeifer_edit

Working Life Interview: Dr Andrea Pfeifer, Co-Founder and CEO, AC Immune

February 11, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AC Immune, Interview, Working Life, feature, pharma

What originally set you off on your career path? Was the plan always to go into the pharma and biotech …

Feature
lilly_building_with_american_flag_web

Eli Lilly’s solanezumab fails at Phase 2/3 in early-onset Alzheimer’s disease

February 11, 2020
Manufacturing and Production Alzheimer's Eli Lilly, pharma, trial failure

In another blow to Alzheimer’s research, it has emerged that a study investigating Eli Lilly’s solanezumab in the treatment of …

News
libtayo

Sanofi and Regeneron’s Libtayo approved on NHS Scotland for cutaneous squamous cell carcinoma

February 11, 2020
Manufacturing and Production, Sales and Marketing Libtayo, NHS, Regeneron, Sanofi, Scotland, nhs scotland, pharma

Scottish patients will now be able to access Sanofi and Regeneron’s Libtayo (cemiplimab) via the NHS after it became known …

News
shutterstock_349943306

85% of patients see benefit in clinical trials, but 43% were never given the option to participate, report finds

February 7, 2020
Medical Communications, Research and Development clinical trials, pharma

Patients regularly find value in participating in clinical trials, but many are not given the option by medical professionals and …

News
gsk_boronia_australia

GSK to axe 720 positions at Belgian vaccine facility

February 7, 2020
Manufacturing and Production, Medical Communications GSK, job cuts, pharma

GlaxoSmithKline has announced a cull of staff at its vaccine production site in Belgium, with 720 employees facing the axe. …

News
abbvie_0

AbbVie’s Rinvoq hits target in psoriatic arthritis sub-population at Phase 3

February 6, 2020
Research and Development AbbVie, Rinvoq, pharma, psoriatic arthritis

AbbVie has unveiled new Phase 3 data on its selective and reversible JAK inhibitor Rinvoq (upadacitinib) in the treatment of …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026